Barbara Bertani, Verona IT
Barbara Bertani, Verona IT
Patent application number | Description | Published |
---|---|---|
20080280919 | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS - Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety. | 11-13-2008 |
20090076274 | BENZOXAZINONE DERIVATIVES, PREPARATION THEREOF AND USES IN THE TREATMENT OF CNS AND OTHER DISORDERS - Intermediates useful in the preparation of compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed: | 03-19-2009 |
20090312546 | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS - Disclosed are methods for the preparation of compounds of formula (I): | 12-17-2009 |
20100035914 | AZABICYCLIC COMPOUNDS AS INHIBITORS OF MONOAMINES REUPTAKE - The present invention relates to novel compounds of formula (I)′, and pharmaceutically acceptable salts, prodrugs or solvates thereof: | 02-11-2010 |
20100063078 | SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or salts thereof: | 03-11-2010 |
20100063097 | Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors - The present invention relates to certain azabicyclic compounds of formula (I)′: | 03-11-2010 |
20100069416 | Azabicyclo [3.1.0] Hexyl Derivatives as Modulators of Dopamine D3 Receptors - The present invention relates to certain azabicyclo compounds of formula (I)′: | 03-18-2010 |
20100204273 | Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors - Disclosed are methods for use of compounds of formula (I) in the treatment of CNS disorders such as dysthymia, schizophrenia, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, pain, and memory disorders: | 08-12-2010 |
20100240661 | AZABICYCLO [3. 1. 0] HEXYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or a salt thereof: | 09-23-2010 |